Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Block Admission Application

26th Mar 2026 15:00

RNS Number : 3093Y
Oxford Nanopore Technologies plc
26 March 2026
 

26 March 2026

Oxford Nanopore Technologies plc (the "Company")

Block Admission Application

The Company confirms that a new block admission application (the "New Block Admission Application") has been made to the London Stock Exchange for 50,000,000 ordinary shares of £0.0001 each in the capital of the Company (the "New Ordinary Shares") to be admitted to trading on the London Stock Exchange's main market for listed securities.

The New Ordinary Shares will, upon issue, rank equally with all other ordinary shares of £0.0001 each in the capital of the Company ("Ordinary Shares") that are then in issue.

The New Ordinary Shares will be issued by the Company from time to time under the terms of the following remuneration plans:

- the Oxford Nanopore Technologies Limited Share Option Scheme;

- the Oxford Nanopore Technologies Limited Share Option Plan 2018;

- the Oxford Nanopore Technologies Limited Long-Term Incentive Plan 2021;

- the Oxford Nanopore Technologies plc Long-Term Incentive Plan 2021;

- the Oxford Nanopore Technologies plc Deferred Bonus Plan 2021;

- the Oxford Nanopore Technologies plc Share Incentive Plan 2021; and

- the Oxford Nanopore Technologies plc Employee Stock Purchase Plan 2021.

The New Block Admission Application is in addition to the Company's existing block admission of 40,000,000 Ordinary Shares announced on 5 October 2021 (the "Existing Block Admission"). Currently, 5,160,512 Ordinary Shares remain subject to its Existing Block Admission.

It is expected that admission of the New Ordinary Shares will become effective on 30 March 2026.

Enquiries:

Investors

[email protected] 

Media 

[email protected]

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZZGZFZVFGVZM

Related Shares:

Oxford Nanopore Technologies
FTSE 100 Latest
Value9,967.35
Change-4.82